- Home
- EVM vs DRTS Comparison
EVM vs DRTS Comparison
Compare EVM & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVM
- DRTS
- Stock Information
- Founded
- EVM 2002
- DRTS 2015
- Country
- EVM United States
- DRTS Israel
- Employees
- EVM N/A
- DRTS N/A
- Industry
- EVM Finance/Investors Services
- DRTS Medical/Dental Instruments
- Sector
- EVM Finance
- DRTS Health Care
- Exchange
- EVM Nasdaq
- DRTS Nasdaq
- Market Cap
- EVM 219.2M
- DRTS 211.7M
- IPO Year
- EVM N/A
- DRTS N/A
- Fundamental
- Price
- EVM $9.02
- DRTS $2.95
- Analyst Decision
- EVM
- DRTS Strong Buy
- Analyst Count
- EVM 0
- DRTS 2
- Target Price
- EVM N/A
- DRTS $8.00
- AVG Volume (30 Days)
- EVM 55.8K
- DRTS 27.4K
- Earning Date
- EVM 01-01-0001
- DRTS 05-19-2025
- Dividend Yield
- EVM 4.01%
- DRTS N/A
- EPS Growth
- EVM N/A
- DRTS N/A
- EPS
- EVM 0.20
- DRTS N/A
- Revenue
- EVM N/A
- DRTS N/A
- Revenue This Year
- EVM N/A
- DRTS N/A
- Revenue Next Year
- EVM N/A
- DRTS N/A
- P/E Ratio
- EVM $47.61
- DRTS N/A
- Revenue Growth
- EVM N/A
- DRTS N/A
- 52 Week Low
- EVM $7.67
- DRTS $1.75
- 52 Week High
- EVM $9.59
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- EVM 51.18
- DRTS 68.40
- Support Level
- EVM $8.89
- DRTS $2.50
- Resistance Level
- EVM $9.14
- DRTS $2.96
- Average True Range (ATR)
- EVM 0.13
- DRTS 0.15
- MACD
- EVM 0.04
- DRTS 0.04
- Stochastic Oscillator
- EVM 73.33
- DRTS 97.83
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income and alternative strategies to institutional investors, both in the United States and internationally.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.